Pharma Co. RevitaLid Approved For Ch. 11 Equity Swap Plan
By Vince Sullivan ( November 20, 2023, 7:11 PM EST) -- Drug company RevitaLid Pharmaceutical Corp. received court approval Monday for its prepackaged Chapter 11 plan that will swap $80 million of its prepetition secured debt for most of the equity in a reorganized company that will continue on as a going concern....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.